PEPTI lays out what 2026 compounding rules mean for peptide patients
The explainer separates what a 503A pharmacy may compound on a prescription from what no pharmacy may ship.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 12 12:00 ETSource: PEPTI
The wire
- 01The post walks through prescription-only compounding, the difference between 503A and 503B pharmacies, and which peptides sit outside either path.
- 02It follows a year of FDA bulk-substance list changes and warning letters that removed several popular peptides from routine compounding.
- 03PEPTI's position: doctor-prescribed, pharmacy-compounded product is the only route it will sell, and its catalog is limited accordingly.
From the source
Read at hellopepti.comCompounded peptides 2026: what patients should know — PEPTI Blog
Compounded peptides 2026 rules are changing fast. Learn what's legal, what's risky, and how doctor-prescribed care protects your plan safely.